Item 1.02 Termination of a Material Definitive Agreement

As previously disclosed, AIM ImmunoTech Inc. (the "Company") is a party to the Equity Distribution Agreement (the "Agreement"), dated April 1, 2025, as amended on April 10, 2026, with Maxim Group LLC (the "Sales Agent"), pursuant to which the Company was able to sell shares of common stock in sales deemed to be an "at the market offering" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. On July 31, 2026, the Company provided notice to the Sales Agent for the mutual termination of the Agreement, effective August 15, 2026 (the "Termination Agreement"). The Company will not incur any termination penalties as a result of the termination of the Agreement.

Following such termination, the Company may not offer or sell any additional shares of its common stock under the Agreement or the related prospectus and prospectus supplement. From April 1, 2025 to July 31, 2026, the Company sold 3,200,736 shares of common stock for aggregate gross proceeds of approximately $2.8 million pursuant to the Agreement. The Company does not intend to issue or sell any additional shares of common stock under the Agreement prior to its termination.

The foregoing description of the Agreement is not complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which was filed as Exhibit 1.1 to the Company's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on April 4, 2025, and the amendment to the Agreement, a copy of which was filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on April 10, 2026, both incorporated herein by reference.

The foregoing description of the Termination Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Termination Agreement, a copy of which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2026 and is incorporated herein by reference.